We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Leveraging the Power of Spatial Context content piece image
Industry Insight

Leveraging the Power of Spatial Context

To learn more about the world's first Microhub – Mica – and some of the areas it could impact the most, Technology Networks spoke to James O’Brien, vice president life sciences at Leica Microsystems.
Women in Science: Perspectives From Industry content piece image
Industry Insight

Women in Science: Perspectives From Industry

In honor of International Day of Women and Girls in Science 2022, Technology Networks interviewed three women who have built successful careers within the scientific industry, to learn about their career paths and the reasons they chose to work in industry.
Gene-Edited Stem Cell-Derived Therapies – A Functional Cure for T1D? content piece image
Industry Insight

Gene-Edited Stem Cell-Derived Therapies – A Functional Cure for T1D?

Technology Networks spoke with Michael Yang, president and chief executive officer of ViaCyte, to learn more about the development of a stem cell-derived therapy for the treatment of T1D and the technology behind it.
Designing in Sustainability in Science content piece image
Industry Insight

Designing in Sustainability in Science

With a reliance on single-use plastics, significant waste and high energy usage, the carbon footprint of the biopharma industry is large. If we are to accelerate the path to net zero, it is therefore critical to ensure sustainability in science.
2022: The Year We Implement COVID-19 Lessons Into Practice content piece image
Industry Insight

2022: The Year We Implement COVID-19 Lessons Into Practice

As we seek a better tomorrow, here are three predictions from global life science and diagnostics company, PerkinElmer, that will lead to better health outcomes.
Transformative Models for Research and Drug Discovery content piece image
Industry Insight

Transformative Models for Research and Drug Discovery

Technology Networks spoke to Dr. Mark Kotter, CEO and founder of bit.bio to learn about opti-ox™ and the development, benefits and applications of ioSkeletal Myocytes.
Raising the Bar in Proteomics content piece image
Industry Insight

Raising the Bar in Proteomics

How do we continue to push the boundaries in analytical capabilities, increase confidence in results and apply MS to a wider range of research questions? Technology Networks posed these questions to Rohan Thakur, executive vice president of Life Sciences Mass Spectrometry at Bruker Daltonics, in a recent interview.
Addressing the Challenges of AAV Production content piece image
Industry Insight

Addressing the Challenges of AAV Production

Technology Networks spoke to Emily Jackson-Holmes to learn more about the benefits of AAV vectors and reasons for the growing interest in their use.
Reinventing Neuroscience Drug Discovery  content piece image
Industry Insight

Reinventing Neuroscience Drug Discovery

Technology Networks had the pleasure of speaking with Saul Kato, the CEO of Herophilus, to learn more about how the company plans to reinvent neuro drug discovery, by combining human brain models, scaled biology and machine learning to decode brain disease.
NanoDrop 20 Years On content piece image
Industry Insight

NanoDrop 20 Years On

In this interview, Patrick Brown tells us more about the evolution of NanoDrop over the past 20 years, highlights some of the most important improvements during this time and explores what the future may hold for the technology.
Advertisement